Compared with high coexpression, low MET/ESR1 coexpression was associated with longer median survival time whether chemotherapy was received or not; however, these differences did not reach statistical significance ( p =0.1778, Figure 6(a)).
← all excerpts
The Impact of the Coexpression of <i>MET</i> and <i>ESR</i> Genes on Prognosticators and Clinical Outcomes of Breast Cancer: An Analysis for the METABRIC Dataset.
1
0.1778
0.1778